Jerry Wu

An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma

Mitchell Ho, Jun S. Wei, J. Khan, 2022, The Journal of clinical investigation.